Manuscripts
Showing 1595 manuscripts.
A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings
Citation
Pachamuthu (Bala) Balakrishnan, Ph.D., Suniti (Daralak) Solomon, M.D., J. Mohanakrishnan, Anitha J. Cecelia, M.Sc., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., K. G. Murugavel, B. Venkatakrishnan, S. S. Solomon, S. M. Crowe, Aylur Kailasam Ganesh, A.C.A., B. Com., S. P. Thyagarajan, Timothy P. Flanigan, M.D., Kenneth H. Mayer, M.D. A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2006 Sep 01; 43(1):23-6.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384
Citation
Rajesh Gandhi, M.D., John Spritzler, Sc.D., Ellen Chan, M.Sc., David M. Asmuth, M.D., Benigno Rodriguez, M.D., Thomas C. Merigan, Jr., M.D., Martin S. Hirsch, M.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Richard B. Pollard, M.D. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. Journal of Acquired Immune Deficiency Syndromes. 2006 Aug 01; 42(4):426-34.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy
Citation
Giovanni Schifitto, M.D., Constantin Yiannoutsos, Ph.D., David M. Simpson, M.D., Christina M. Marra, M.D., Elyse J. Singer, M.D., Dennis Kolson, M.D., Ph.D., Avindra Nath, M.D., Joseph R. Berger, M.D., Bradford A. Navia, M.D. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. Journal of Neurovirology. 2006 Aug 01; 12(4):328-31. PMID: 16966223.Year
2006
Journal
Journal of Neurovirology
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study
Citation
Alison A. Motsinger, Marylyn D. Ritchie, Ph.D., Robert Shafer, M.D., Gregory K. Robbins, M.D., M.P.H., Gene D. Morse, Pharm.D., Line Labbe, Ph.D., Grant R Wilkinson, Ph.D., D.Sc., David B. Clifford, M.D., Richard T. D'Aquila, M.D., Victoria A. Johnson, M.D., Richard B. Pollard, M.D., Thomas C. Merigan, Jr., M.D., Martin S. Hirsch, M.D., John P. Donahue, Richard B. Kim, M.D., David W. Haas, M.D. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenetics and Genomics. 2006 Nov 01; 16(11):837-45.Year
2006
Journal
Pharmacogenetics and Genomics
Impact of pregnancy on abacavir pharmacokinetics
Citation
Brookie M. Best, Mark Mirochnick, Edmund V Capparelli, Alice Stek, Sandra K Burchett, Diane T Holland, Jennifer S Read, Elizabeth Smith, Chengcheng Hu, Stephen A Spector, James D Connor, PACTG P1026s Study Team. Impact of pregnancy on abacavir pharmacokinetics. AIDS. 2006 Feb 28; 20(4):553-560. PMID: 16470119.Year
2006
Journal
AIDS
Study
P1026S
In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.
Citation
Susan Brogly, Ph.D., Paige L. Williams, Ph.D., George Seage, III, Sc.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Russell B. Van Dyke, M.D., James M. Oleske, M.D. In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts. Journal of Acquired Immune Deficiency Syndromes. 2006 Apr 01; 41(4):535-536.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S.
Citation
Kumud K. Singh, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Stephen A. Spector, M.D. Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S. AIDS. 2006 Mar 14; 20(3):475-478.Year
2006
Journal
AIDS
Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Citation
Paige L. Williams, Ph.D., Deborah S. Storm, R.N.,Ph.D, Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Betsy Kammerer, Ph.D., Patricia Sirois, Ph.D., John J. Farley, M.D., M.P.H., Kathleen Malee, Ph.D. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006 Dec 01; 118(6):e1745 - e1757. PMID: 17101712.Year
2006
Journal
Pediatrics
Reduced lopinavir exposure during pregnancy.
Citation
Alice M. Stek, Mark Mirochnick, Edmund Capparelli, Brookie M. Best, ChengCheng Hu, Sandra K. Burchett, Carol Elgie, Diane T. Holland, Elizabeth Smith, Ruth Tuomala, Amanda Cotter, Jennifer S. Read. Reduced lopinavir exposure during pregnancy. AIDS. 2006 Oct 03; 20(15):1931 - 1939. PMID: 16988514.Year
2006
Journal
AIDS
Study
P1026S
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Citation
Mark J. Abzug, M.D., Stephen Ira Pelton, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Myron Levin, M.D., Sharon Appelbaum Nachman, M.D., William Borkowsky, M.D., Howard Max Rosenblatt, M.D., John F. Marcinak, M.D., Arry Dieudonne, M.D., Elaine J. Abrams, M.D., Indu Pathak. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatric Infectious Disease Journal. 2006 Oct 01; 25(10):920 - 929. PMID: 17006288.Year
2006
Journal
Pediatric Infectious Disease Journal
Study
P1024